Impact of Fatty Stimuli on Cerebral Activity in Anorexia Nervosa: a Multi-sensory Approach
ANOVERSION
2 other identifiers
interventional
90
1 country
1
Brief Summary
Lipid restriction is significant in anorexia nervosa and limits therapeutic management. The multisensory perception of fat is altered, creating an aversion to lipids. The investigators aim to characterize the impact of sensory stimulation (smells or images) associated with specific tastes using neuropsychological assessments and functional MRI. Some volatile aromas can enhance the perception of the associated taste. The investigators hypothesize that such associations are altered in anorexia nervosa for fatty foods but may be preserved for sweet tastes, and that this alteration contributes to the maintenance of the disease. The interdependence of different sensory perceptions of lipids could play a major role in the therapeutic approach, aiding in the deconditioning of this aversion and the restoration of positive food sensory associations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedFirst Posted
Study publicly available on registry
January 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2027
January 15, 2026
January 1, 2026
1.8 years
December 22, 2025
January 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Brain activity measured by functional MRI
Estimation of the "fatty vs. neutral" contrast when all three senses are used, comparing AN patients to the normal-weight control group (NC group) in each voxel of the brain volume (whole-brain analysis) and in the orbitofrontal cortex (ROI analysis).
Day 1
Secondary Outcomes (6)
Brain activity measured by functional MRI
Day 1
Brain activity measured by functional MRI
Day 1
Brain activity measured by functional MRI
Day 1
BMI
DAY 1.
Olfactory and gustatory abilities
Day 1
- +1 more secondary outcomes
Study Arms (3)
Anorexia Nervosa patient group
EXPERIMENTAL30 patients with anorexia nervosa
Normal Weight Control group
ACTIVE COMPARATOR30 control subjects of normal weight
Low Weight Control group
ACTIVE COMPARATOR30 control subjects with a similar weight to AN patients (the constitutional thinness group)
Interventions
One hour MRI examination
one hour sensory testings
Eligibility Criteria
You may qualify if:
- Person affiliated or entitled to a social security scheme
- Person having received informed information on the study and having co-signed, with the investigator, a consent to participate in the study
- female person
- Person affiliated or entitled to a social security scheme
- Over 18 years'old
- Knowing how to read and write French
- Patient diagnosed with anorexia nervosa according to DSM-5 criteria for at least 5 years (HAS criteria). Failure of prior outpatient or/and hospitalization care over the last 12 months: stable or falling low BMI, unmodified food restriction, continued fear of weight gain, disturbances in the perception of body image
- BMI \< 18.5 kg/m² for volunteers in a state of constitutional thinness. The absence of eating disorder and the absence of restriction to DEBQ questionnaires. Fertility preserved.
- For volunteers of normal weight: 18.5 kg/m² \< BMI \< 25 kg/m²
You may not qualify if:
- Pregnant women, parturient, nursing mothers;
- Persons deprived of their liberty, hospitalized without consent, hospitalized for purposes other than research;
- Minors
- Refusal of the study by the participant
- Person incapable of giving informed consent
- Artificial nutrition
- Associated organic damage favoring undernutrition: other chronic diseases (digestive, infectious, endocrine, pulmonary, cardiac, neurological), neoplasms, etc.
- Abuse of psychoactive substances except tobacco
- Characterized depressive episode, psychosis
- Score less than 14 on the Edinburgh laterality questionnaire.
- Contraindications to MRI or allergy to one of the components of the olfactory and taste tests
- Smokers
- Smell or taste alterations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Saint-Etienne
Saint-Etienne, 42055, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2025
First Posted
January 15, 2026
Study Start
January 1, 2026
Primary Completion (Estimated)
November 1, 2027
Study Completion (Estimated)
November 1, 2027
Last Updated
January 15, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share